Personalized Cancer Vaccines Market Overview
The Personalized Cancer Vaccines Market is projected to surge from $4.4 billion in 2024 to $25 billion by 2035, reflecting a robust CAGR of 17.1%. These vaccines represent a groundbreaking approach in oncology, tailoring immunotherapy to individual patient tumor profiles through genomic profiling and neoantigen identification. Unlike traditional vaccines, personalized cancer vaccines train the...
0 Comments 0 Shares 58 Views 0 Reviews